The best way to market in the EU: the centralised or decentralised procedure?

By Sarah Faircliffe

04-2012

Mary Smillie and Sarah Faircliffe reflect on patterns of usage of the different routes to approval in the EU, with a particular focus on generics.

 

Click here to read the full article

 

This article was published in the April 2012 issue of Scrip Regulatory Affairs.

 

Authors